Feedback / Questions
AM-401 - Altamira Therap
https://www.globenewswire.com/news-release/2024/01/24/2815348/0/en/Altamira-Therapeutics-Files-Second-Provisional-Patent-Application-for-OligoPhore-Nanoparticles-Targeting-Different-KRAS-Mutations-in-Cancer-Treatment.html
Jan 24, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next